Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISA 2020 | Localized amyloidosis: symptoms and site of disease

Eli Muchtar • 9 Sep 2020
ISA 2020
Amyloidosis Rare Diseases

Localized amyloidosis is typically immunoglobulin light chain associated (AL), although serum amyloid A protein and transthyretin have also been reported as causing localized disease. Localized amyloidosis often involves the laryngo-tracheobronchial tree, urogenital tract, and skin. Eli Muchtar, MD, Mayo Clinic, Rochester, MN, discusses localized amyloidosis compared to systemic amyloidosis, with localized amyloidosis diagnosis based on symptoms and site of localized disease. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Eli Muchtar

1:43
Feasibility of double autologous stem cell transplantation in patients with AL amyloidosis
Eli Muchtar • 6 Sep 2022
1:02
Incidence of hypovitaminosis D in patients with renal AL amyloidosis
Eli Muchtar • 6 Sep 2022
2:18
Using AI to predict light chain amyloidosis in patients with MGUS and SMM
Eli Muchtar • 6 Sep 2022
6:10
Auto-HSCT in AL amyloidosis
Eli Muchtar • 9 Sep 2020

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
0:58
Hematological manifestations associated with primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals